Omnicell Inc. Stock
Price
Target price
€37.40
€37.40
-1.580%
-0.6
-1.580%
€35.34
03.10.24 / Frankfurt
WKN: 632313 / Symbol: OMCL / Name: Omnicell / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omnicell Inc. Stock
We can see a decrease in the price for Omnicell Inc.. Compared to yesterday it has lost -€0.600 (-1.580%).
Currently there is a rather positive sentiment for Omnicell Inc. with 3 Buy predictions and 1 Sell predictions.
On the other hand, the target price of 35 € is below the current price of 37.4 € for Omnicell Inc., so the potential is actually -6.42%.
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -1.580% | -2.094% | -5.076% | -10.096% | 6.857% | -71.450% | -43.333% |
| Integer Hldg | -1.740% | 0.000% | -1.739% | 53.741% | 26.966% | 44.872% | 69.925% |
| Healthequity Inc. | -2.080% | -0.704% | -4.082% | 3.676% | 18.487% | 26.753% | 41.566% |
| Bruker Corp. | 3.440% | -3.569% | 5.022% | 1.767% | -8.180% | - | - |
Comments
Omnicell, Inc. (NASDAQ: OMCL) had its price target raised by analysts at Bank of America Co. from $34.00 to $44.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $38.00 price target on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell, Inc. (NASDAQ: OMCL) had its price target lowered by analysts at Benchmark Co. from $42.00 to $38.00. They now have a "buy" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat